Theravance Biopharma Inc (NAS:TBPH)
$ 9.115 -0.075 (-0.82%) Market Cap: 448.22 Mil Enterprise Value: 406.02 Mil PE Ratio: 0 PB Ratio: 2.41 GF Score: 71/100

Q3 2024 Theravance Biopharma Inc Earnings Call Transcript

Nov 12, 2024 / 10:00PM GMT
Release Date Price: $8.91 (-1.87%)
Operator

Ladies and gentlemen. Good afternoon. I'd like to welcome everyone to the Fair Advance Bio former third quarter, 2024 conference call. During the presentation, all participants will be in a listen-only mode, a question and answer session will follow the company's formal formal remarks to ask a question. Press star, press the star key followed by the digit one digit one on your phone. Again, that's star 11 to ask the question. If listening via webcast, please mute your audio on your webcast advice before asking a question over the phone. I'll repeat the instructions after manvi completes their prepared remarks. Also, today's conference call is being recorded and now I'd like to turn the conference over to Rick Whittingham, Chief Executive Officer. Please go ahead, sir.

Rick Winningham
Theravance Biopharma Inc - Chairman of the Board, Chief Executive Officer

Good afternoon and welcome to the Advance by Cors third quarter, 2024 earnings results conference call. I encourage you to review our forward-looking statements. Disclaimer on slide 2 which covers certain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot